Bin L. Liang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

Transarterial infusion chemotherapy combined with lenvatinib and tislelizumab versus intravenous chemotherapy for unresectable pancreatic ductal adenocarcinoma: a retrospective propensity score matching analysis.

Transarterial infusion chemotherapy combined with lenvatinib and tislelizumab versus intravenous chemotherapy for unresectable pancreatic ductal adenocarcinoma: a retrospective propensity score matching analysis.

Journal: Frontiers in oncology

Published: June 02, 2026

Calcification-Mediated Dual-Starvation and Immune Activation for Transarterial Chemoembolization.

Calcification-Mediated Dual-Starvation and Immune Activation for Transarterial Chemoembolization.

Journal: International journal of nanomedicine

Published: March 27, 2026

Efficacy and Safety of HAIC Plus Regorafenib and Icaritin in Advanced Hepatocellular Carcinoma After First-Line Lenvatinib Failure: A Retrospective Analysis.

Efficacy and Safety of HAIC Plus Regorafenib and Icaritin in Advanced Hepatocellular Carcinoma After First-Line Lenvatinib Failure: A Retrospective Analysis.

Journal: Anti-cancer agents in medicinal chemistry

Published: February 03, 2026

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.

Journal: Gut

Published: December 22, 2025

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Journal: Cancers

Published: November 28, 2025

Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review.

Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review.

Journal: Frontiers in oncology

Published: November 18, 2025

Hyaluronidase optimizes TACE in hepatocellular carcinoma by remodeling tumor stroma and enhancing chemotherapy penetration.

Hyaluronidase optimizes TACE in hepatocellular carcinoma by remodeling tumor stroma and enhancing chemotherapy penetration.

Journal: International journal of biological macromolecules

Published: November 09, 2025

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization.

Journal: Archivos de bronconeumologia

Published: November 04, 2025

Clinical outcomes after TIPS: comparison of patients with a history of partial splenic embolization vs splenectomy in cirrhosis.

Clinical outcomes after TIPS: comparison of patients with a history of partial splenic embolization vs splenectomy in cirrhosis.

Journal: European radiology

Published: May 28, 2025

Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements.

Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements.

Journal: Current oncology (Toronto, Ont.)

Published: April 11, 2025

Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial.

Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial.

Journal: Nature medicine

Published: January 23, 2025

Feasibility, efficacy, and safety of ventral caudal artery access for transarterial chemoembolization in a rat hepatocellular carcinoma model.

Feasibility, efficacy, and safety of ventral caudal artery access for transarterial chemoembolization in a rat hepatocellular carcinoma model.

Journal: BMC gastroenterology

Published: January 17, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026